Dustin A Deming Selected Research

LY3023414

1/2017

Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dustin A Deming Research Topics

Disease

36	Neoplasms (Cancer) 07/2023 - 06/2012
18	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 06/2012
8	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2014
4	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 02/2017
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2016
2	Microsatellite Instability 01/2023 - 11/2017
2	Neutropenia 10/2022 - 01/2019
2	Fatigue 10/2022 - 04/2014
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2022 - 08/2013
2	Rectal Neoplasms (Rectal Cancer) 12/2020 - 01/2017
2	Carcinogenesis 01/2019 - 01/2014
2	Adenoma (Adenomas) 01/2018 - 01/2014
1	Lymphoma (Lymphomas) 10/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Prostatic Neoplasms (Prostate Cancer) 09/2021
1	Residual Neoplasm 12/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Cytopenia 01/2019
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2017
1	Carcinoma (Carcinomatosis) 01/2014
1	Intestinal Neoplasms (Intestinal Cancer) 01/2014
1	Adenocarcinoma 01/2014

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 06/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2017
3	sapanisertibIBA 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2019
3	Temozolomide (Temodar)FDA LinkGeneric 10/2020 - 02/2017
3	veliparibIBA 08/2019 - 01/2017
3	CateninsIBA 01/2019 - 01/2014
3	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 06/2012
3	Capecitabine (Xeloda)FDA Link 01/2017 - 08/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 06/2017
2	CrizotinibIBA 01/2023 - 01/2020
2	cabozantinibIBA 01/2023 - 01/2020
2	Versicans (Versican)IBA 01/2022 - 01/2017
2	Proteoglycans (Proteoglycan)IBA 01/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 06/2012
2	dactolisibIBA 01/2019 - 01/2017
2	Cetuximab (Erbitux)FDA Link 06/2017 - 04/2016
1	pembrolizumabIBA 01/2023
1	IpilimumabIBA 10/2022
1	Gemcitabine FDA Link 10/2022
1	Transaminases (Aminotransferases)IBA 10/2022
1	NivolumabIBA 10/2022
1	copanlisibIBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2022
1	LigandsIBA 10/2022
1	Death Domain ReceptorsIBA 10/2022
1	navitoclaxIBA 01/2022
1	entrectinibIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2022
1	Profilins (Profilin)IBA 11/2021
1	Interferon-gamma (Interferon, gamma)IBA 11/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2021
1	trifluridine tipiracil drug combinationIBA 10/2020
1	Everolimus FDA Link 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	CarcinogensIBA 01/2019
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2019
1	AntibodiesIBA 12/2018
1	Cyclic AMP (AMP, Cyclic)IBA 01/2018
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 11/2017
1	RamucirumabIBA 06/2017
1	Monoclonal AntibodiesIBA 06/2017
1	Panitumumab (Vectibix)FDA Link 06/2017
1	Trastuzumab (Herceptin)FDA Link 06/2017
1	Bevacizumab (Avastin)FDA Link 06/2017
1	human ERBB2 proteinIBA 06/2017
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2017
1	MTOR InhibitorsIBA 01/2017
1	LY3023414IBA 01/2017
1	AZD 6244IBA 04/2016
1	Cre recombinaseIBA 10/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 02/2015
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 02/2015
1	Bortezomib (Velcade)FDA Link 04/2014
1	Vorinostat FDA Link 04/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	CLR1502IBA 01/2014
1	Dextrans (Dextran)FDA Link 01/2014

Therapy/Procedure

16	Therapeutics 01/2023 - 01/2016
7	Drug Therapy (Chemotherapy) 01/2023 - 08/2013
6	Precision Medicine 07/2023 - 09/2015
3	Radiotherapy 01/2023 - 01/2017
3	Immunotherapy 03/2021 - 01/2017
2	Aftercare (After-Treatment) 01/2016 - 01/2013
1	Hyperthermic Intraperitoneal Chemotherapy 01/2023
1	Cytoreduction Surgical Procedures 01/2023
1	Prostatectomy (Retropubic Prostatectomy) 09/2021
1	Biological Therapy 06/2017